BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3080822)

  • 1. Sodium 2-mercaptoethane sulfonate protection against cyclophosphamide-induced teratogenicity in rats.
    Slott VL; Hales BF
    Toxicol Appl Pharmacol; 1986 Jan; 82(1):80-6. PubMed ID: 3080822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of reduced glutathione with 2-mercaptoethane sulfonate to prevent cyclophosphamide-induced urotoxicity.
    Cavalletti E; Tofanetti O; Zunino F
    Cancer Lett; 1986 Jul; 32(1):1-6. PubMed ID: 3091245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro/in vivo effects of Mesna on the genotoxicity and toxicity of cyclophosphamide--a study aimed at clarifying the mechanism of Mesna's anticarcinogenic activity.
    Pool BL; Bos RP; Niemeyer U; Theuws JL; Schmähl D
    Toxicol Lett; 1988 Apr; 41(1):49-56. PubMed ID: 3128896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Mesna (2-mercaptoethane sulfonate) with the mutagenicity of cyclophosphamide in vitro and in vivo.
    Lähdetie J; Räty R; Sorsa M
    Mutat Res; 1990 Sep; 245(1):27-32. PubMed ID: 2118231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).
    Brock N; Pohl J; Stekar J; Scheef W
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1377-87. PubMed ID: 6819957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the uroprotector sodium 2-mercaptoethane sulfonate (Mesna) on the proliferation of the bladder urothelium in the rat after administration of cyclophosphamide.
    Kunze E; Köhnecke B; Engelhardt W; Steinröder H; Brock N; Pohl J
    Urol Int; 1984; 39(2):61-7. PubMed ID: 6426112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).
    Habs MR; Schmähl D
    Cancer; 1983 Feb; 51(4):606-9. PubMed ID: 6401591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
    Brock N; Stekar J
    Arzneimittelforschung; 1982; 32(5):486-7. PubMed ID: 6809014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].
    Schmähl D; Habs M; Tacchi AM
    Urologe A; 1984 Sep; 23(5):291-6. PubMed ID: 6438859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.
    Freedman A; Ehrlich RM; Ljung BM
    J Urol; 1984 Sep; 132(3):580-2. PubMed ID: 6433044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism.
    Berrigan MJ; Marinello AJ; Pavelic Z; Williams CJ; Struck RF; Gurtoo HL
    Cancer Res; 1982 Sep; 42(9):3688-95. PubMed ID: 6809312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on hemotoxicity of cyclophosphamide, doxorubicin and cis-diamminodichloroplatinum combined with sodium-2-mercaptoethane sulfonate.
    Lerza R; Bogliolo G; Mencoboni M; Saviane A; Pannacciulli I
    Tumori; 1988 Jun; 74(3):333-7. PubMed ID: 3135644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
    Ozcan A; Korkmaz A; Oter S; Coskun O
    Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine and sodium 2-mercaptoethane sulfonate as sources of urinary thiol groups in the rat.
    Ormstad K; Ohno Y
    Cancer Res; 1984 Sep; 44(9):3797-800. PubMed ID: 6430554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effect of piperonyl butoxide on cyclophosphamide-induced teratogenesis in rats.
    Park D; Kim S; Kang H; Oh J; Jang JY; Shin S; Kim TK; Choi YJ; Lee SH; Kim KY; Joo SS; Kim YB
    Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):402-8. PubMed ID: 19851987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Licorice extract increases cyclophosphamide teratogenicity by upregulating the expression of cytochrome P-450 2B mRNA.
    Park D; Yang YH; Choi EK; Yang G; Bae DK; Lee SH; Kim TK; Kyung J; Kim D; Choi KC; Kim YB
    Birth Defects Res B Dev Reprod Toxicol; 2011 Dec; 92(6):553-9. PubMed ID: 21818843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of cyclophosphamide-induced hemorrhagic cystitis by resveratrol: a comparative experimental study with mesna.
    Keles I; Bozkurt MF; Cemek M; Karalar M; Hazini A; Alpdagtas S; Keles H; Yildiz T; Ceylan C; Buyukokuroglu ME
    Int Urol Nephrol; 2014 Dec; 46(12):2301-10. PubMed ID: 25248628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevention of cyclophosphamide-induced bladder swelling in the rat by I.V. administration of sodium-2-mercaptoethane sulfonate.
    Kedar A; Simpson CL; Williams P; Moore R; Tritsch G; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):339-48. PubMed ID: 6774389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide.
    Wagner T; Zink M; Schwieder G
    J Cancer Res Clin Oncol; 1987; 113(2):160-5. PubMed ID: 3104347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does 2-mercaptoethane sulphonate (mesna) prevent cyclophosphamide and azathioprine induced immunosuppression? In vitro studies.
    Al-Safi SA; Maddocks JL
    Br J Clin Pharmacol; 1986 Mar; 21(3):267-70. PubMed ID: 2938613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.